Moreover, some studies suggest that increased number of CD19+ B cells was found in patients with severe vs. mild-to-moderate COVID19 infection [15], whereas others evidence about significantly reduced proportion of B cells mirroring escalating severity of COVID-19 [18]. The gene discussed is CD19; the disease is COVID-19.